MHRA approves UK’s first immunotherapy for type 1 diabetes

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield; Sanofi) for delaying the progression of type 1 diabetes mellitus (T1DM). The treatment is the UK’s first approved immunotherapy for the disease and has been licensed for patients aged 8 years and over. It is administered through an intravenous infusion once daily for […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.369383
Primary Topic: Geochemistry and Geologic Mapping
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

MHRA approves UK’s first immunotherapy for type 1 diabetes

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Geochemistry and Geologic Mapping

article

MHRA approves UK’s first immunotherapy for type 1 diabetes

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Openalex Percentile: Top 70%

Geochemistry and Geologic Mapping

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MHRA approves UK’s first immunotherapy for type 1 diabetes · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS